AMERICAS COMMITTEE FOR TREATMENT AND RESEARCH IN MULTIPLE SCLEROSIS INC (EIN 264496795) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2009

Legal Domicile

Principal Officer

JENNIFER BRYDGES

Phone

6083108960

Tax Period

2024-10-01 to 2025-09-30

AMERICAS COMMITTEE FOR TREATMENT AND RESEARCH IN MULTIPLE SCLEROSIS INC, founded in 2009, is a community nonprofit in the Human Services sector that reported $2.9M in total revenue in fiscal year 2024. Revenue decreased 7% compared to the prior year. Expenses of $3.8M exceeded revenue, resulting in a 33% operating deficit.

Mission

ACTRIMS IS A COMMUNITY OF LEADERS DEDICATED TO THE TREATMENT OF AND RESEARCH IN MULTIPLE SCLEROSIS, DISSEMINATION OF KNOWLEDGE AND EDUCATION, AND COLLABORATION AMONG DISCIPLINES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $1,045,282

Program Service Revenue $676,083

Investment Income $1,133,119

Other Revenue $7,905

TOTAL REVENUE $2,862,389

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $12,754

Program Expenses $3,384,788

Other Expenses $3,801,089

TOTAL EXPENSES $3,801,089

Year-over-Year Comparison

	2024	2023	Change
Revenue	$2,862,389	$3,069,785	-0.1%
Expenses	$3,801,089	$3,844,366	0.0%
Net Income	$-938,700	$-774,581	+0.2%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
EMMANUELLE WAUBANT	PRESIDENT	1.00	Officer Director	$0	$0	$0
BENJAMIN SEGAL	PRESIDENT-ELECT	1.00	Officer Director	$0	$0	$0
FIONA COSTELLO	TREASURER	1.00	Officer Director	$0	$0	$0
MYLA GOLDMAN	SECRETARY	1.00	Officer Director	$0	$0	$0
MARK FREEDMAN	DIRECTOR	1.00	Director	$0	$0	$0
TANUJA CHITNIS	DIRECTOR	1.00	Director	$0	$0	$0
CATHERINE LAROCHELLE	DIRECTOR	1.00	Director	$0	$0	$0
ERIN LONGBRAKE	DIRECTOR	1.00	Director	$0	$0	$0
ROBERT NAISMITH	DIRECTOR	1.00	Director	$0	$0	$0
DANIEL ONTANEDA	DIRECTOR	1.00	Director	$0	$0	$0
ALEXANDRE PRAT	DIRECTOR	1.00	Director	$0	$0	$0
DANIEL REICH	DIRECTOR	1.00	Director	$0	$0	$0
V WEE YONG	DIRECTOR	1.00	Director	$0	$0	$0
VERONIQUE MIRON	DIRECTOR	1.00	Director	$0	$0	$0
JENNIFER BRYDGES	CHIEF EXECUTIVE OFFICER	16.00	Officer	$0	$0	$0
KARIE KRANTZ	MANAGING DIRECTOR	16.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$2,862,389	$3,801,089	$9,376,930	$-938,700
2024	$3,069,785	$3,844,366	$10,319,672	$-774,581
2023	$2,455,534	$2,865,693	$10,068,863	$-410,159
2022	$1,998,178	$2,804,267	$9,333,800	$-806,089
2021	$1,381,210	$1,173,309	$12,764,269	$207,901
2020	$9,051,856	$4,548,438	$11,974,736	$4,503,418
2019	$1,659,643	$2,495,649	$6,175,135	$-836,006
2018	$1,657,706	$1,716,709	$7,157,743	$-59,003

AMERICAS COMMITTEE FOR TREATMENT AND RESEARCH IN MULTIPLE SCLEROSIS INC